Type 1 Diabetes Prediction and Prevention (DIPP) Study

Summary

The Type 1 Diabetes Prediction and Prevention (DIPP) Study in Finland is a population-based long-term clinical follow-up study established since 1994 in three university hospitals in Finland to understand the pathogenesis of type 1 diabetes (T1D), predict the disease, and find preventive treatment.

Conditions

• Type 1 Diabetes Mellitus

Interventions

OTHER

No intervention. DIPP is an observational study.

Sponsors & Collaborators

• Oulu University Hospital

  collaborator OTHER

• University of Turku

  collaborator OTHER

• Turku University Hospital

  collaborator OTHER_GOV

• Tampere University

  collaborator OTHER

• Tampere University Hospital

  collaborator OTHER

• Juvenile Diabetes Research Foundation

  collaborator OTHER

• The Leona M. and Harry B. Helmsley Charitable Trust

  collaborator OTHER

• Riitta Veijola

  lead OTHER

Principal Investigators

• Riitta Veijola, MD PhD · University of Oulu, Oulu University Hospital

• Mikael Knip, MD PhD · University of Helsinki, Tampere University Hospital

• Jorma Toppari, MD PhD · University of Turku, Turku University Hospital

• Kalle Kurppa, MD PhD · Tampere University

• Heikki Hyöty, MD PhD · Tampere University

• Johanna Lempainen, MD PhD · University of Turku

Eligibility

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

1994-11-07

Primary Completion

2024-12-31

Completion

2024-12-31

Countries

• Finland

Study Locations